Requests that FDA declare that Labetalol Hydrochloride Tablets, 50 mg and 150 mg, are suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2025-P-7056
Documents
5
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.